{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T19:19:18Z","timestamp":1784920758905,"version":"3.55.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.cmi.2023.11.006","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T05:07:50Z","timestamp":1700284070000},"page":"211-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Single-dose cefixime 800 mg plus doxycycline 100 mg twice a day for 7\u00a0days compared with single-dose ceftriaxone 1 g plus single-dose azithromycin 2 g for treatment of urogenital, rectal, and pharyngeal gonorrhoea: a randomised clinical trial"],"prefix":"10.1016","volume":"30","author":[{"given":"Beatrice","family":"B\u00ed\u017eov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u0159emysl","family":"Proch\u00e1zka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elka","family":"Ny\u010dov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Bo\u0159il","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kubele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pol\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Zemanov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Unemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Rob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cmi.2023.11.006_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41572-019-0128-6","article-title":"Gonorrhoea","volume":"5","author":"Unemo","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.cmi.2023.11.006_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4939-9496-0_3","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae and treatment of gonorrhea","volume":"1997","author":"Unemo","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"3","key":"10.1016\/j.cmi.2023.11.006_bib4","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2023.11.006_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/0956462420949126","article-title":"2020 European guideline for the diagnosis and treatment of gonorrhoea in adults. Preprint","author":"Unemo","year":"2020","journal-title":"Int J STD AIDS"},{"issue":"4","key":"10.1016\/j.cmi.2023.11.006_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"10.1016\/j.cmi.2023.11.006_bib7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/cid\/ciab074","article-title":"The staying power of pharyngeal gonorrhea: implications for public health and antimicrobial resistance","volume":"73","author":"Adamson","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.cmi.2023.11.006_bib8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/sextrans-2014-051731","article-title":"Will targeting oropharyngeal gonorrhoea delay the further emergence of drug-resistant Neisseria gonorrhoeae strains?","volume":"91","author":"Lewis","year":"2015","journal-title":"Sex Transm Infect"},{"issue":"3","key":"10.1016\/j.cmi.2023.11.006_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/OLQ.0000000000001742","article-title":"Effectiveness of cefixime for the treatment of Neisseria gonorrhoeae infection at 3 anatomic sites: A systematic review and meta-analysis","volume":"50","author":"Yang","year":"2023","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.cmi.2023.11.006_bib10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/sti.2010.042812","article-title":"Evaluation of the cobas 4800 CT\/NG test for detecting Chlamydia trachomatis and Neisseria gonorrhoeae","volume":"86","author":"Rockett","year":"2010","journal-title":"Sex Transm Infect"},{"issue":"2","key":"10.1016\/j.cmi.2023.11.006_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cmi.2019.08.004","article-title":"Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial","volume":"26","author":"Rob","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.cmi.2023.11.006_bib12","doi-asserted-by":"crossref","first-page":"e627","DOI":"10.1016\/S2666-5247(21)00171-3","article-title":"WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: A retrospective observational study","volume":"2","author":"Unemo","year":"2021","journal-title":"Lancet Microbe"},{"issue":"3","key":"10.1016\/j.cmi.2023.11.006_bib13","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"10.1016\/j.cmi.2023.11.006_bib14","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/jac\/dkad129","article-title":"Important considerations regarding the widespread use of doxycycline chemoprophylaxis against sexually transmitted infections","volume":"78","author":"Kong","year":"2023","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"14","key":"10.1016\/j.cmi.2023.11.006_bib15","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa2211934","article-title":"Postexposure doxycycline to prevent bacterial sexually transmitted infections","volume":"388","author":"Luetkemeyer","year":"2023","journal-title":"N\u00a0Engl J Med"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23005645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23005645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T20:38:53Z","timestamp":1741293533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X23005645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1198743X23005645"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2023.11.006","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-dose cefixime 800 mg plus doxycycline 100 mg twice a day for 7\u00a0days compared with single-dose ceftriaxone 1 g plus single-dose azithromycin 2 g for treatment of urogenital, rectal, and pharyngeal gonorrhoea: a randomised clinical trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2023.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}